Summary of the "Rapid and durable protection against Ebola virus with new vaccine regimens."
NIH/National Institute of Allergy and Infectious Diseases
The world is coming closer to developing a vaccine for the deadly Ebola Virus. New Clinical trials on monkeys have shown promise and are making progress with two out four monkeys being protected when injected with the vaccine ChAd3 10 months after vaccination. The research team headed by Nancy J. Sullivan, Ph.D of the National Institute of Allergy and Infectious Diseases inoculated four monkeys with the ChAd3 Ebola vaccine, then 8 weeks later with a booster vaccine containing ebola virus gene segments incorporated into a different vector (a poxvirus). Four out of four monkeys in this trial survived. The world is coming closer to finding a cure.
Although in my opinion I think the world should be moving much faster at finding a cure & vaccine. The studies shown are promising and world health agencies should immediately begin expediting the process of clinical trials on humans to get this drug approved and begin implementing it in the field to begin treating patients. The world as a whole needs to treat the threat of this virus more seriously and move with more pace into creating and perfecting the treatment and drugs used to cure it.
NIH/National Institute of Allergy and Infectious Diseases. (2014, September 8). Rapid and durable protection against Ebola virus with new vaccine regimens. ScienceDaily. Retrieved September 10, 2014 from www.sciencedaily.com/releases/2014/09/140908152930.htm
I totally agree with you: the world needs to take this seriously and move faster. I can't help but wonder if there would be more money and effort to fight this if it were affecting people in the First World.
ReplyDelete